Densan Co Ltd
TSE:3640
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Densan Co Ltd
Cash Equivalents
Densan Co Ltd
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Densan Co Ltd
TSE:3640
|
Cash Equivalents
ÂĄ1.6B
|
CAGR 3-Years
33%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-2%
|
|
transcosmos Inc
TSE:9715
|
Cash Equivalents
ÂĄ64.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
GMO Payment Gateway Inc
TSE:3769
|
Cash Equivalents
ÂĄ166.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
31%
|
CAGR 10-Years
24%
|
|
Relia Inc
TSE:4708
|
Cash Equivalents
ÂĄ27.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
Bellsystem24 Holdings Inc
TSE:6183
|
Cash Equivalents
ÂĄ7.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
TKC Corp
TSE:9746
|
Cash Equivalents
ÂĄ31.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
See Also
What is Densan Co Ltd's Cash Equivalents?
Cash Equivalents
1.6B
JPY
Based on the financial report for Mar 31, 2024, Densan Co Ltd's Cash Equivalents amounts to 1.6B JPY.
What is Densan Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-2%
Over the last year, the Cash Equivalents growth was 20%. The average annual Cash Equivalents growth rates for Densan Co Ltd have been 33% over the past three years , 23% over the past five years , and -2% over the past ten years .